Address correspondence to Jonathan A. Finkelstein, M.D., M.P.H., Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Avenue, 6th Floor, Boston, MA. Dr. Finkelstein is also with the Division of General Pediatrics, Children's Hospital, Boston. Paula Lozano, M.D., M.P.H., is with the Department of Pediatrics, University of Washington, and the Center for Health Studies, Group Health Cooperative, Seattle, WA. Anne L. Fuhlbrigge, M.D., M.S., Vincent J. Carey, Ph.D., Scott T. Weiss, M.D., are with the Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Thomas S. Inui, Sc.M., M.D., is with The Regenstrief Institute for Health Care, 1050 Wishard Blvd, RG-6, Indianapolis, IN. Stephen B. Soumerai, Sc.D., is with the Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA. Sean D. Sullivan, Ph.D., is with the Department of Pharmacy, School of Public Health and Community Medicine, and Director, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA. Edward H. Wagner, M.D., M.P.H., is with the MacColl Institute for Healthcare Innovation, Center for Health Studies, Group Health Cooperative, Seattle, WA. Kevin B. Weiss, M.D., is with the Midwest Center for Health Services and Policy Research, Hines VA Hospital, and the Institute for Healthcare Studies and Division of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
1475-6773/asset/HESR_left.gif?v=1&s=e1aefc6479f5e5bfb0939ee5cf47664a10a5284c)
1475-6773/asset/HESR_centre.gif?v=1&s=214ade28bc6ce575c2996d5bbf437466f695ada9)
1475-6773/asset/HESR_right.gif?v=1&s=b41919a083fd565ed8cb6b14c656f8af2160073b)
Practice-Level Effects of Interventions to Improve Asthma Care in Primary Care Settings: The Pediatric Asthma Care Patient Outcomes Research Team
Article first published online: 15 AUG 2005
DOI: 10.1111/j.1475-6773.2005.00451.x
Additional Information
How to Cite
Finkelstein, J. A., Lozano, P., Fuhlbrigge, A. L., Carey, V. J., Inui, T. S., Soumerai, S. B., Sullivan, S. D., Wagner, E. H., Weiss, S. T. and Weiss, K. B. (2005), Practice-Level Effects of Interventions to Improve Asthma Care in Primary Care Settings: The Pediatric Asthma Care Patient Outcomes Research Team. Health Services Research, 40: 1737–1757. doi: 10.1111/j.1475-6773.2005.00451.x
Publication History
- Issue published online: 15 AUG 2005
- Article first published online: 15 AUG 2005
- Abstract
- Article
- References
- Cited By
Keywords:
- Asthma care;
- randomized controlled trial;
- chronic care model;
- physician behavior change
Objective. To assess the practice-level effects of (1) a physician peer leader intervention and (2) peer leaders in combination with the introduction of asthma education nurses to facilitate care improvement. And, to compare findings with previously reported patient-level outcomes of trial enrollees.
Study Setting. Data were included on children 5–17 years old with asthma in 40 primary care practices, affiliated with managed health care plans enrolled in the Pediatric Asthma Care Patient Outcomes Research Team (PORT) randomized trial.
Study Design. Primary care practices were randomly assigned to one of two care improvement arms or to usual care. Automated claims data were analyzed for 12-month periods using a repeated cross-sectional design. The primary outcome was evidence of at least one controller medication dispensed among patients with persistent asthma. Secondary outcomes included controller dispensing among all identified asthmatics, evidence of chronic controller use, and the dispensing of oral steroids. Health service utilization outcomes included numbers of ambulatory visits and hospital-based events.
Principal Findings. The proportion of children with persistent asthma prescribed controllers increased in all study arms. No effect of the interventions on the proportion receiving controllers was detected (peer leader intervention effect 0.01, 95 percent confidence interval [CI]: −0.07, 0.08; planned care intervention effect −0.03, 95 percent CI: −0.09, 0.02). A statistical trend was seen toward an increased number of oral corticosteroid bursts dispensed in intervention practices. Significant adjusted increases in ambulatory visits of 0.08–0.10 visits per child per year were seen in the first intervention year, but only a statistical trend in these outcomes persisted into the second year of follow-up. No differences in hospital-based events were detected.
Conclusions. This analysis showed a slight increase in ambulatory asthma visits as a result of asthma care improvement interventions, using automated data. The absence of detectable impact on medication use at the practice level differs from the positive intervention effect observed in patient self-reported data from trial enrollees. Analysis of automated data on nonenrollees adds information about practice-level impact of care improvement strategies. Benefits of practice-level interventions may accrue disproportionately to the subgroup of trial enrollees. The effect of such interventions may be less apparent at the level of practices or health plans.